At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 26 enrolled
Drug / intervention
Testosterone +1 moredrug
Likely dose
Testosterone 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of Cyclic Testosterone Administration on Muscle Function in Older Individuals
The University of Texas Medical Branch, Galveston·interventional·Posted Aug 12, 2009·Updated Sep 10, 2012
In Brief
A Phase 1 clinical trial evaluating Testosterone and Placebo for Hypogonadism. Completed, enrolled 26 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether testosterone (male hormone) therapy is effective if administered in a cyclic fashion (periodic dosing) compared to continuous dosing in men aged 60 to 85 years. Effectiveness will be determined based on improvements in body composition, muscle metabolism, muscle strength, and bone metabolism.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypogonadism
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2006
Primary CompletionDec 2008
First PostedAug 2009
TodayJul 2026
First PostedAug 12, 2009
Enrollment StartJan 1, 2006
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 16.9 years ago
Interventions
Testosteronedrug
Weekly im injections of 100 mg testosterone enanthate.
Placebodrug
Weekly IM injections of sesame oil.